Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Integrative Computational Analysis of the Putative Molecular Crosstalk Between Diabetes Mellitus and Pancreatic Cancer: A Network Pharmacology Study of Nisha-Amalaki.

Created on 18 Nov 2026

Authors

Haresh Sivakumar, Kae Shin Sim, Chun Hoe Tan

Published in

Omics : a journal of integrative biology. Pages 15578100261505563. Nov 17, 2026. Epub Nov 17, 2026.

Abstract

Nisha-Amalaki (NA), an Ayurvedic formulation of Curcuma longa (Nisha) and Emblica officinalis (Amalaki), is traditionally used for glycemic control and antioxidant support. Since diabetes mellitus (DM) and pancreatic cancer (PC) share metabolic-inflammatory mechanisms, this study employed integrative computational approaches to identify NA phytochemicals and their putative molecular targets mediating dual antidiabetic and anticancer effects. NA phytochemicals were retrieved from databases and literature, filtered through ADMET and drug-likeness criteria, and mapped to DM- and PC-related genes. From 311 reported NA phytochemicals, curcumin (an.), divanillalaceton, and caffeic acid emerged as principal phytochemicals. Enrichment analysis implicated IL-6/JAK/STAT3, apical junction, and apoptosis pathways. Box plot analysis showed all 14 hub genes were upregulated in PC tissues, while high EGFR and MMP1 expression correlated with poorer survival. Among the 14 hub genes, eight key genes were further refined by topology algorithms, that is, APP, TLR4, NOS2, EGFR, MMP9, STAT3, NFE2L2, and ALOX5. Cytotoxicity predictions suggested potential antiproliferative activity of the phytochemicals against multiple PC cell lines. Molecular docking and dynamics indicated thermodynamically stable phytochemical-target interactions, with curcumin (an.) showing stronger EGFR binding than gefitinib. This study provides computational evidence supporting NA's potential in treating PC and DM; probably via modulating inflammatory, metabolic, and junctional pathways.

PMID:
43046161
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement